0

Female Contraceptive Market by Distribution Channel, Product and Geography - Forecast and Analysis 2023-2027

  • Published: Nov 2022
  • Pages: 168
  • SKU: IRTNTR70642
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The female contraceptive market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million. The growth of the market depends on several factors, including the increasing adoption of innovative marketing strategies, evolving consumer perspectives, and the availability of different methods of contraception.

This report extensively covers market segmentation by distribution channel (offline and online), product (female contraceptive devices and female contraceptive drugs), and geography (North America, Europe, APAC, South America, and the Middle East and Africa). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

 What will the Size of the Female Contraceptive Market be During the Forecast Period?

Female Contraceptive Market Size

To learn more about this report, Download Report Sample

Parent Market Analysis

Technavio categorizes the global female contraceptive market as a part of the global personal products market within the global household and personal products market. The parent global personal products market covers products and companies engaged in research and development (R and D) and the production of personal and beauty care products, including cosmetics and perfumes. The scope of the global personal products market also includes personalized gifts, sleep masks, sex toys, hair wigs and extensions, and polarized sunglasses markets. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Female Contraceptive Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing adoption of innovative marketing strategies is notably driving the market growth, although factors such as non-uniformity in sex education in developed countries may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Female Contraceptive Market Driver 

The increasing adoption of innovative marketing strategies is the key factor driving the global female contraceptive market growth. Vendors are making significant investments in advertising and marketing, which is driving the growth of the market. Leading contraceptive brands have increased their marketing expenditure to maintain their leading positions in the market. Various PR activities are being conducted to increase the curiosity among women to experiment with female contraceptives such as birth control pills.

Other marketing approaches involve print advertisements and events that have garnered the attention of women from various demographics. This is likely to increase the demand for birth control pills among users. Through extensive marketing, vendors can popularize their range of products. Short-term video advertisements also increase awareness about female contraceptives. They encourage users to have conversations about birth control with doctors, which leads them to try out different brands. These initiatives increase the sales of birth control pills, which drives the growth of the market.

Key Female Contraceptive Market Trend.

The increasing popularity of female condoms will fuel the global female contraceptive market growth. The market has been witnessing the rising popularity of female condoms in the past two years. In developed countries, the adoption of female condoms is increasing, which is creating a demand for such products. In the US, the government is distributing a large number of female condoms through beauty salons, convenience stores, and clinics under its DC program to curb the rising rates of HIV infections in the country. Also, trained officials communicate with women to know about their sexual health, which helps achieve higher acceptance rates for female condoms.

Moreover, the second-generation female condoms manufactured by FH2 (a brand of Veru) have reduced the cost of female condoms and made their pricing equivalent to that of male condoms. Female condoms are critically important, especially for high-risk sex workers who may face condom refusal. Also, they are an ideal alternative to contraceptive pills for women who prefer not to use hormonal methods to prevent pregnancy. Therefore, these factors are increasing the popularity of female condoms globally.

Key Female Contraceptive Market Challenge

Non-uniformity in sex education in developed countries is a major challenge to the global female contraceptive market growth. While developed countries such as the US consider themselves sexually liberated countries, non-uniformity in imparting sex education is affecting awareness of sex among teenagers, which is reducing the demand for female contraceptives. If teenagers are not educated properly about the various aspects of sex, the use of female contraceptives will be limited among them.

In the US, in several states, there is a focus on abstinence-only sex education, which is a form of sex education that promotes and teaches students not to have sex outside marriage or premarital sex. Furthermore, such education excludes the teaching of birth control measures and safe sex. This has increased teenage pregnancy rates. Therefore, unless proper and scientifically accurate sex education is imparted in schools, the adoption of products such as female condoms will be low, as teenagers will not be aware of the availability of such products. This could affect the growth of the global female contraceptive market during the forecast period.

Key Female Contraceptive Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Female Contraceptive Market Share by Geography

Global Female Contraceptive Market Customer Landscape

 

Who are the Major Female Contraceptive Market Vendors?                                     

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

abbvie.com - The company offers female contraceptives such as Liletta Intrauterine Contraceptive. Also, under this segment, the company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve its established long-term strategic goals.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Afaxys Pharma LLC
  • Agile Therapeutics Inc.
  • Amgen Inc.
  • Ansell Ltd.
  • Bayer AG
  • CooperSurgical Inc.
  • Cupid Ltd.
  • Exeltis USA Inc.
  • Johnson & Johnson
  • Mayer Laboratories Inc.
  • Medisafe Distribution Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • Pfizer Inc.
  • Piramal Enterprises Ltd.

A qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Female Contraceptive Market?

The market share growth by the offline segment will be significant during the forecast period. This segment includes adult stores and vending machines. The segment will grow at a moderate rate due to the low presence of these stores near residential complexes and localities. However, with the growing real estate sector, these establishments are setting up bases close to family neighborhoods to sustain healthy revenue. This segment affects the sales of convenience stores, merchandisers, and drugstores to an extent.

Female Contraceptive Market Size

Get a glance at the market contribution of various segments  Request a PDF Sample

The offline segment showed a gradual increase in market share with USD 10,036.76 million in 2017 and continued to grow by 2021Vending machines also contribute significant revenue to the segment and the global market. Countries such as the US, the UK, France, Germany, China, and Japan have a large number of branded condom vending machines. Also, in many countries, governments, health organizations, and NGOs are installing vending machines that provide condoms at a low cost, which is expected to drive the growth of the segment during the forecast period. 

Which are the Key Regions for the Female Contraceptive Market?

Female Contraceptive Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

North America is projected to contribute 38% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The female contraceptive market in North America is growing due to high product penetration and availability. The availability of advanced female contraceptive products such as IUDs has driven the growth of the market in the region. As these devices are considered effective in preventing pregnancies and are cost-effective as they are generally used for longer periods of time, their demand is increasing in the region.

This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. COVID-19 led to a surge in the demand for female contraceptives in North America. However, in the second half of 2020, the COVID-related restrictions were somewhat relaxed in various countries, which led to the resumption of business activities and essential services, including the availability of OTC contraceptives. The relaxation of such restrictions has encouraged people to go for health checkups and treatments, which is expected to drive the growth of the female contraceptive market in North America during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by distribution channel, product, and region.

  • Distribution Channel Outlook ( USD Million, 2017 - 2027)
    • Offline
    • Online 
  • Product Outlook ( USD Million, 2017 - 2027)
    • Female contraceptive devices
    • Female contraceptive drugs
  • Region Outlook ( USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • North America
      • Chile
      • Brazil
      • Colombia
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Female Contraceptive Market Scope

Report Coverage

Details

Page number

168

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 5.32%

Market growth 2023-2027

$5,142.22 million

Market structure

Fragmented

YoY growth (%)

4.2

Regional analysis

North America, Europe, APAC, South America, and the Middle East, and Africa

Performing market contribution

North America at 38%

Key countries

US, Canada, China, Japan, and France

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Female Contraceptive Market Report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the female contraceptive market and its contribution to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behavior.
  • Growth of the market industry across North America, Europe, APAC, South America, and the Middle East and Africa.
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of female contraceptive market vendors.

 

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global female contraceptive market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global female contraceptive market 2017 - 2021 ($ million)
    • 4.2 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 32: Chart on Comparison by Distribution Channel
      • Exhibit 33: Data Table on Comparison by Distribution Channel
    • 6.3 Offline - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
    • 6.4 Online - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Distribution Channel
      • Exhibit 42: Market opportunity by Distribution Channel ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 43: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 45: Chart on Comparison by Product
      • Exhibit 46: Data Table on Comparison by Product
    • 7.3 Female contraceptive devices - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
    • 7.4 Female contraceptive drugs - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 55: Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 57: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 59: Chart on Geographic comparison
      • Exhibit 60: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 APAC - Market size and forecast 2022-2027
      • Exhibit 69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on APAC - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
    • 9.6 South America - Market size and forecast 2022-2027
      • Exhibit 73: Chart on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on South America - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on South America - Year-over-year growth 2022-2027 (%)
    • 9.7 Middle East and Africa - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • 9.8 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 France - Market size and forecast 2022-2027
      • Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 108: AbbVie Inc. - Overview
              • Exhibit 109: AbbVie Inc. - Product / Service
              • Exhibit 110: AbbVie Inc. - Key offerings
            • 12.4 Afaxys Pharma LLC
              • Exhibit 111: Afaxys Pharma LLC - Overview
              • Exhibit 112: Afaxys Pharma LLC - Product / Service
              • Exhibit 113: Afaxys Pharma LLC - Key offerings
            • 12.5 Agile Therapeutics Inc.
              • Exhibit 114: Agile Therapeutics Inc. - Overview
              • Exhibit 115: Agile Therapeutics Inc. - Product / Service
              • Exhibit 116: Agile Therapeutics Inc. - Key offerings
            • 12.6 Ansell Ltd.
              • Exhibit 117: Ansell Ltd. - Overview
              • Exhibit 118: Ansell Ltd. - Business segments
              • Exhibit 119: Ansell Ltd. - Key news
              • Exhibit 120: Ansell Ltd. - Key offerings
              • Exhibit 121: Ansell Ltd. - Segment focus
            • 12.7 Bayer AG
              • Exhibit 122: Bayer AG - Overview
              • Exhibit 123: Bayer AG - Business segments
              • Exhibit 124: Bayer AG - Key offerings
              • Exhibit 125: Bayer AG - Segment focus
            • 12.8 CooperSurgical Inc.
              • Exhibit 126: CooperSurgical Inc. - Overview
              • Exhibit 127: CooperSurgical Inc. - Product / Service
              • Exhibit 128: CooperSurgical Inc. - Key offerings
            • 12.9 Cupid Ltd.
              • Exhibit 129: Cupid Ltd. - Overview
              • Exhibit 130: Cupid Ltd. - Product / Service
              • Exhibit 131: Cupid Ltd. - Key offerings
            • 12.10 Johnson and Johnson
              • Exhibit 132: Johnson and Johnson - Overview
              • Exhibit 133: Johnson and Johnson - Business segments
              • Exhibit 134: Johnson and Johnson - Key news
              • Exhibit 135: Johnson and Johnson - Key offerings
              • Exhibit 136: Johnson and Johnson - Segment focus
            • 12.11 Mayer Laboratories Inc.
              • Exhibit 137: Mayer Laboratories Inc. - Overview
              • Exhibit 138: Mayer Laboratories Inc. - Product / Service
              • Exhibit 139: Mayer Laboratories Inc. - Key offerings
            • 12.12 Merck and Co. Inc.
              • Exhibit 140: Merck and Co. Inc. - Overview
              • Exhibit 141: Merck and Co. Inc. - Business segments
              • Exhibit 142: Merck and Co. Inc. - Key news
              • Exhibit 143: Merck and Co. Inc. - Key offerings
              • Exhibit 144: Merck and Co. Inc. - Segment focus
            • 12.13 Mylan NV
              • Exhibit 145: Mylan NV - Overview
              • Exhibit 146: Mylan NV - Business segments
              • Exhibit 147: Mylan NV - Key offerings
              • Exhibit 148: Mylan NV - Segment focus
            • 12.14 Pfizer Inc.
              • Exhibit 149: Pfizer Inc. - Overview
              • Exhibit 150: Pfizer Inc. - Product / Service
              • Exhibit 151: Pfizer Inc. - Key news
              • Exhibit 152: Pfizer Inc. - Key offerings
            • 12.15 Reckitt Benckiser Group PLC
              • Exhibit 153: Reckitt Benckiser Group PLC - Overview
              • Exhibit 154: Reckitt Benckiser Group PLC - Business segments
              • Exhibit 155: Reckitt Benckiser Group PLC - Key offerings
              • Exhibit 156: Reckitt Benckiser Group PLC - Segment focus
            • 12.16 Teva Pharmaceutical Industries Ltd.
              • Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.17 Veru Inc.
              • Exhibit 162: Veru Inc. - Overview
              • Exhibit 163: Veru Inc. - Business segments
              • Exhibit 164: Veru Inc. - Key offerings
              • Exhibit 165: Veru Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 166: Inclusions checklist
                • Exhibit 167: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 168: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 169: Research methodology
                • Exhibit 170: Validation techniques employed for market sizing
                • Exhibit 171: Information sources
              • 13.5 List of abbreviations
                • Exhibit 172: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Female Contraceptive market growth will increase by $2309.79 million during 2020-2025.
              The female contraceptive market is expected to grow at a CAGR of 3.00% during 2020-2025.
              Technavio has segmented the female contraceptive market by product (Female contraceptive devices and Female contraceptive drugs) and geographic (North America, Europe, Asia, and ROW).
              Bayer AG, Foundation Consumer Healthcare LLC, Johnson & Johnson Inc., Lupin Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Merck KGaA, Pfizer Inc., The Cooper Companies Inc., Veru Inc are a few of the key vendors in the female contraceptive market.
              North America will register the highest growth rate of 34.71% among the other regions. Therefore, the female contraceptive market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the female contraceptive market growth are:
              • Increasing adoption of innovative marketing strategies
              • Increasing popularity of female condoms
              The female contraceptive market vendors should focus on grabbing business opportunities from the female contraceptive devices segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>